NewMed Medical Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
NewMed Medical Co., Ltd. - overview
Established
2015
Location
Shanghai, -, China
Primary Industry
Medical Devices & Equipment
About
NewMed Medical Co. , Ltd. , based in China, specializes in developing innovative medical devices for cardiac care, focusing on heart valve replacement procedures to enhance patient outcomes and surgical success. Founded in 2015 and headquartered in Shanghai, China, NewMed Medical Co.
, Ltd. operates in the medical device industry, concentrating on cardiac solutions. The company's journey includes raising a total of CNY 100. 000 mn through various funding rounds, with the latest round being a Series B that took place on March 25, 2021.
Fortune Capital was among the investors in this round, emphasizing the company's appeal in the investment landscape. NewMed Medical Co. , Ltd. offers innovative solutions in cardiac care, particularly in simplifying heart valve replacement procedures.
Their product range includes advanced medical devices aimed at minimizing treatment risks and improving surgery success rates. The company caters primarily to hospitals and healthcare providers within the Chinese market while also exploring international applications for their technology. Their commitment to research and collaboration within the academic sphere supports their objective of enhancing patient outcomes through technological advancements. NewMed Medical Co.
, Ltd. generates revenue through direct sales of their medical devices to healthcare institutions, engaging in B2B transactions with hospitals and clinics. Their pricing strategies are structured to support healthcare providers in the procurement process, with revenue primarily derived from bulk orders and contractual partnerships, ensuring their innovative solutions are effectively delivered to end-users. Looking ahead, NewMed Medical Co.
, Ltd. is focused on launching new products that enhance cardiac care technologies. Recent funding from the Series B round will facilitate these initiatives, as well as support expansion into additional markets. Specifically, the company aims to target broader international markets, enhancing their presence beyond China by the end of 2023.
With a solid foundation in research and product development, NewMed Medical is positioning itself for greater market penetration and continued innovation in the medical device sector.
Current Investors
LYZZ Capital, Tahoe Venture Group, OrbiMed Advisors
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.newmed.cn
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.